(1)
Breschi, G. L.; Demma, F.; Morelli, P.; De Francesco, M. Brentuximab Vedotin in Adult Patients With HL CD30+ at High Risk of Relapse or Progression Following ASCT: A Cost-Analysis in Italy. AboutOpen 2021, 8, 81-87.